These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 862206)

  • 41. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
    Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
    Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C; Beck B; Kolopp M; Toussain P; Debry G
    Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucagon response to arginine stimulation in obese and diabetic children.
    Meschi F; Garlaschi C; Di Natale B; Del Guercio MJ; Gargantini L; Chiumello G
    Diabetes; 1977 Jun; 26(6):558-60. PubMed ID: 863126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test.
    Menzel R; Pusch H; Ratzmann GW; Besch W; Förster F; Albrecht G; Ruhnke R
    Exp Clin Endocrinol; 1985 Feb; 85(1):81-8. PubMed ID: 3886415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
    Palmer JP; Benson JW; Walter RM; Ensinck JW
    J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes.
    Polonsky KS; Herold KC; Gilden JL; Bergenstal RM; Fang VS; Moossa AR; Jaspan JB
    Diabetes; 1984 Nov; 33(11):1112-9. PubMed ID: 6389228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
    Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
    Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
    Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
    Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.
    Waldhäusl W; Bratusch-Marrain P; Nowotny P
    Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.
    Shah P; Vella A; Basu A; Basu R; Schwenk WF; Rizza RA
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4053-9. PubMed ID: 11095432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
    Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
    Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of octreotide on growth hormone, IGF-I, IGFBP-3, glucagon, cortisol and epinephrine response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients.
    Lunetta M; Di Mauro M; Le Moli R; Nicoletti F
    Diabetes Metab; 1997 Dec; 23(6):524-7. PubMed ID: 9496559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma glucagon and alanine responses to acute insulin deficiency in man.
    Gerich JE; Tsalikian E; Lorenzi M; Karam JH; Bier DM
    J Clin Endocrinol Metab; 1975 Mar; 40(3):526-9. PubMed ID: 1117061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell.
    Shichiri M; Kawamori R; Abe H
    Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of somatostatin on blood sugar, plasma growth hormone, and glucagon levels in diabetic children.
    Del Guercio MJ; di Natale B; Gargantini L; Garlaschi C; Chiumello G
    Diabetes; 1976 Jul; 25(7):550-3. PubMed ID: 1278605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Counterregulatory hormonal responses to rapid glucose lowering in diabetic man.
    Lilavivathana U; Brodows RG; Woolf PD; Campbell RG
    Diabetes; 1979 Oct; 28(10):873-7. PubMed ID: 478181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.
    Willms B; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Nauck MA
    J Clin Endocrinol Metab; 1996 Jan; 81(1):327-32. PubMed ID: 8550773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epinephrine-induced hypoaminoacidemia in normal and diabetic human subjects: effect of beta blockade.
    Shamoon H; Jacob R; Sherwin RS
    Diabetes; 1980 Nov; 29(11):875-81. PubMed ID: 7000585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.